Rentabilidad en el año
| Fondo | Fecha | |||||
|---|---|---|---|---|---|---|
| 2025 | ||||||
| Resultados por página: 10 | 20 | 50 | 100Se muestran de 171 a 180 de un total de 37477 fondos | ||||||
| PICTET - BIOTECH HI EUR | 26/11 | 48,48% | ||||
| CAIXABANK BOLSA GESTION ESPAÑA, FI PLUS | 26/11 | 48,35% | ||||
| ALKEN FUND - EUROPEAN OPPORTUNITIES US2 | 27/11 | 48,28% | ||||
| ALKEN FUND - EUROPEAN OPPORTUNITIES GB1 | 27/11 | 48,23% | ||||
| ALKEN FUND - EUROPEAN OPPORTUNITIES CH1 | 27/11 | 48,20% | ||||
| POLAR CAPITAL GLOBAL TECHNOLOGY R EUR CAP HEDGED | 26/11 | 48,15% | ||||
| ALKEN FUND - EUROPEAN OPPORTUNITIES CH2 | 27/11 | 48,12% | ||||
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 EUR HEDGED | 27/11 | 48,07% | ||||
| SANTANDER SMALL CAPS ESPAÑA, FI A | 26/11 | 48,06% | ||||
| POLAR CAPITAL GLOBAL TECHNOLOGY R EUR DIS HEDGED | 26/11 | 48,05% | ||||
